Central Pharmaceutical JSC No2 (HSTC:DP2) Research & Development: ₫ Mil (TTM As of . 20)


HSTC:DP2 Central Pharmaceutical JSC No2 HSTC:DP2
23 GF Score
Price ₫4,500.00
View Full Analysis

What is Central Pharmaceutical JSC No2 Research & Development?

Central Pharmaceutical JSC No2 HSTC:DP2 23 Research & Development is ₫ Mil as of . 20. GuruFocus rates HSTC:DP2 with a GF Score™ of 23/100.

Research & Development is the aggregate amount of research and development expenses during the year. Central Pharmaceutical JSC No2's Research & Development for the six months ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2 does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Central Pharmaceutical JSC No2  (HSTC:DP2) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Central Pharmaceutical JSC No2 Research & Development Related Terms

Central Pharmaceutical JSC No2 Research & Development Historical Data

* Premium members only.

The historical data trend for Central Pharmaceutical JSC No2's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceutical JSC No2 Research & Development Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Research & Development

Central Pharmaceutical JSC No2 Semi-Annual Data
Research & Development
HSTC:DP2
23GF Score
Central Pharmaceutical JSC No2 HSTC:DP2
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Pharmaceutical JSC No2 Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₫ Mil mean?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a Research & Development of ₫ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Central Pharmaceutical JSC No2 and its competitors.
Is Central Pharmaceutical JSC No2's Research & Development too high?
Central Pharmaceutical JSC No2's current Research & Development is ₫ Mil. Overall, Central Pharmaceutical JSC No2 has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Central Pharmaceutical JSC No2's Research & Development compare to ?
Central Pharmaceutical JSC No2's Research & Development of ₫ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Central Pharmaceutical JSC No2 and its competitors. Central Pharmaceutical JSC No2's current Research & Development is ₫ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Pharmaceutical JSC No2 stock overvalued right now?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a current Research & Development of ₫ Mil. The current Research & Development is ₫ Mil. Central Pharmaceutical JSC No2's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Central Pharmaceutical JSC No2 (HSTC:DP2), the current Research & Development is ₫ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Central Pharmaceutical JSC No2 Business Description

Comparable Companies
Address No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.
23GF Score

Get the complete analysis for HSTC:DP2

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫4,500.00
Price